Argicayenne
Natural health product licensed in Canada
- Licence holder
- les Laboratoires Améa Ltée
- NPN or DIN-HM
- 80031722
- Status
- Active licence
- Licence date
- 25 April 2012
- Revision date
- Not provided
- Form
- Pâte
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
alcool benzylique, Illite, 3-acétyl-2-hydroxy-6-méthyl-pyran-4-one
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 12 years | Not specified | minimum: 3 days ; maximum: 4 days |
| Adolescents | Not specified | Not specified | minimum: 3 days ; maximum: 4 days |
| Adultes | Not specified | Not specified | minimum: 3 days ; maximum: 4 days |
Uses authorised in Canada
Utilisé pour le soulagement temporaire des douleurs musculaires et articulaires associées à l'arthrite rhumatoïde ou à l'arthrose, et de la douleur des tendons et des ligaments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031722
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.